The Chinese Ministry of Health has found no clinical evidence to link Synutra’s infant milk products and premature breast growth in three infant girls.

Tests found no signs of inappropriate hormones and the Ministry said yesterday (15 August) that, when looking at similar cases of precocious puberty in recent years, there was no heightened risk of being affected through using infant formula compared to breast feeding.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The move follows a week of speculation in the Chinese media that hormones in infant formula from Chinese firm Synutra was responsible for the early development. Synutra has vehemently defended the safety of its products.

The Ministry said it did not find any unusual levels of hormones in the 73 samples it tested, of which 42 were Synutra’s milk, and one sample of milk residue from one of the infants’ homes.

 

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now